Cargando…
On the Dark Side of Therapies with Immunoglobulin Concentrates: The Adverse Events
Therapy by human immunoglobulin G (IgG) concentrates is a success story ongoing for decades with an ever increasing demand for this plasma product. The success of IgG concentrates on a clinical level is documented by the slowly increasing number of registered indication and the more rapid increase o...
Autores principales: | Späth, Peter J., Granata, Guido, La Marra, Fabiola, Kuijpers, Taco W., Quinti, Isabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318428/ https://www.ncbi.nlm.nih.gov/pubmed/25699039 http://dx.doi.org/10.3389/fimmu.2015.00011 |
Ejemplares similares
-
Editorial: Immunoglobulin Therapy in the 21st Century – the Dark Side of the Moon
por: Farrugia, Albert, et al.
Publicado: (2015) -
Is Dosing of Therapeutic Immunoglobulins Optimal? A Review of a Three-Decade Long Debate in Europe
por: Kerr, Jacqueline, et al.
Publicado: (2014) -
Longitudinal Study on Health-Related Quality of Life in a Cohort of 96 Patients with Common Variable Immune Deficiencies
por: Tabolli, Stefano, et al.
Publicado: (2014) -
Manufacture of Immunoglobulin Products for Patients with Primary Antibody Deficiencies – The Effect of Processing Conditions on Product Safety and Efficacy
por: Farrugia, Albert, et al.
Publicado: (2014) -
Adverse Effects of Immunoglobulin Therapy
por: Guo, Yi, et al.
Publicado: (2018)